Ewa Litwa
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Subregion-specific perineuronal net remodelling in the dorsal hippocampus drives vulnerability and resilience to chronic stress: The role of venlafaxine treatment.
Journal: British journal of pharmacology
Published: March 02, 2026
Metabolic stress-response in female rats: β-oxidation-induced vulnerability vs adaptive resilience.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 30, 2025
Ventral hippocampal autophagy and mitophagy dynamics shape behavioral responses to chronic mild stress in adult male rats.
Journal: Neurobiology of stress
Published: August 12, 2025
Editorial: Neuropharmacological intervention for severe mental illness and suicide prevention.
Journal: Frontiers in pharmacology
Published: March 24, 2025
Efficacy of Venlafaxine and Deep Brain Stimulation Against the Effects of Hippocampal Lesion with Ibotenic Acid in Animals Exposed to the Chronic Mild Stress Model of Depression.
Journal: Current neuropharmacology
Published: February 07, 2025
The antidepressant-like activity of ketamine in the rat chronic mild stress model requires activation of cortical 5-HT 1A receptors.
Journal: Behavioural pharmacology
Published: December 24, 2024
Trends in research on novel antidepressant treatments.
Journal: Frontiers in pharmacology
Published: December 13, 2024
The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms.
Journal: Journal of psychopharmacology (Oxford, England)
Published: June 03, 2024
Exposure to an acute stress impaired the metabolic plasticity of resilient rats by enhancing fatty acid β-oxidation in the ventral hippocampus.
Journal: Translational psychiatry
Published: February 21, 2024
Venlafaxine's effect on resilience to stress is associated with a shift in the balance between glucose and fatty acid utilization.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: April 14, 2023
Chronic N-Acetyl-Cysteine Treatment Enhances the Expression of the Immediate Early Gene Nr4a1 in Response to an Acute Challenge in Male Rats: Comparison with the Antidepressant Venlafaxine.
Journal: International journal of molecular sciences
Published: February 22, 2023
The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, display ketamine-like RAAD and anti-TRD activities in rat CMS models.
Journal: Psychopharmacology
Published: January 23, 2023
Last Updated: 09/26/2026